<DOC>
	<DOCNO>NCT02063126</DOCNO>
	<brief_summary>The main objective evaluate safety efficacy oral Reconnect ® ( food supplementation compose Coenzyme Q10 , NADH , phosphoserine vitamin C ) maximum HR exercise test CFS</brief_summary>
	<brief_title>Clinical Trial Measure Maximun HR After ReConnect ® Supplementation v . Placebo CFS .</brief_title>
	<detailed_description>Chronic Fatigue Syndrome ( CFS ) serious , complex extremely debilitate chronic illness , often misunderstand characterize prolonged fatigue , hallmark condition multiple nonspecific symptom . The World Health Organization recognize CFS disease affect nervous system ( ICD-10 G93.3 ) multiple body system . The etiology unknown . Previous study demonstrate CFS patient significant reduction plasma intracellular Peripheral Blood Mononuclear Cells concentration Coenzyme Q10 NADH , correlate clinical symptom disease . Hypothesis : Supplementation CoQ10 plus NADH could beneficial improvement clinical molecular parameter disease . The primary endpoint evaluate efficacy oral Reconnect ® suplementation maximum heart rate change exercise test CFS . The secondary endpoint evaluate effect Reconnect ® suplementation perception fatigue ( assessed FIS ) , pain ( McGill Pain Index Questionnaire ) , sleep disruption ( Pittsburgh Sleep Index Questionnaire ) . Patients Methods : A total 80 consecutive woman patient diagnosis CFS accord 1994 CDC Fukuda 's definition criterion initially evaluate enrolled study . The majority exclude meet inclusion criterion study . All subject treatment ReConnect® contain CoQ10 plus NADH versus placebo . Fatigue level , pain sleep disturbance score use Fatigue Impact Scale , McGill Pain Questionnaire Pittsburgh Sleep Quality Index , respectively . Discussion : To knowledge , previous study yet evaluate effectiveness oral ReConnect supplementation CFS . ReConnect contain combination CoQ10 plus NADH nutrient ( phosphoserine Vitamin C ) help improve clinical symptom restore mitochondrial function oxidative stress reduce fatigue , pain sleep impairment CFS . The combination supplement result safe effective therapy reduce fatigue , pain improve sleep well help restore quality life CFS patient .</detailed_description>
	<mesh_term>Fatigue</mesh_term>
	<mesh_term>Fatigue Syndrome , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Ascorbic Acid</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<criteria>Patients female 18 65 year old . CFS patient diagnose Chronic Fatigue Syndrome ( CFS Clinical Unit , Vall d'Hebron Hospital , Barcelona , Spain ) Heart rate radial pulse seat 50 to100 bpm , systolic BP 100 140 mm Hg diastolic BP 50 90 mm Hg . Patients give write informed consent initiate study . Patients contraindicate advisable carryout ergometer exercise test . Patients participate another clinical trial differents nature last 30 day prior inclusion . Any participant , opinion investigator , may able follow instruction make good treatment compliance . Subjects give write informed consent participate study . Participants receive drug ban substance expect withdrawal medications/products allow study involve significants problem .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>Coenzyme Q10 plus NADH</keyword>
	<keyword>maximum Heart Rate</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Pain</keyword>
	<keyword>Sleep</keyword>
</DOC>